November 11, 2019
Metabotropic Glutamate Receptor 3

Metabotropic Glutamate Receptor 3 – Pipeline Review, H1 2019

Summary

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the universities/institutes. The latest report Metabotropic Glutamate Receptor 3 – Pipeline Review, H1 2019, outlays comprehensive information on Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) – Metabotropic glutamate receptor 3 is a G protein-coupled receptor encoded by the GRM3 gene. L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions.

Furthermore, this report also reviews key players involved in Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Get Free Sample Research Report on Metabotropic Glutamate Receptor

Scope

– The report reviews Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report reviews the latest news and deals related to Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted therapeutics

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand the targeted therapy areas and indications for Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3)

For complete Research , please ask for Full Report

https://www.jsbmarketresearch.com/pharmaceuticals/metabotropic-glutamate-receptor-3-pipeline-review-h1

Related Report

E3 Ubiquitin Protein Ligase XIAP – Pipeline Review, H1 2019

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 – Pipeline Review, H1 2019

JSB market research is one of the most significant databases of online market research and intelligence reports and services. we specialize in providing market research reports for various industries.the online portal for marketing research deals with access to global market data and assists in providing expert.

Contact Us

JSB Market Research

Phone: +917710006748

Website: www.jsbmarketresearch.com

Email: enquiry@jsbmarketresearch.com

Blog: https://www.jsbmarketresearch.com/blog/


adminglobal

Hi, Thank you for landing on my page! To quickly brief about me, I happen to work with JSB Market as a research analyst. Business and Industrial domains are vast and everchanging! and it's fascinating! To share this fascination about business and industrial facts and events, I'll be posting blogs on similar subjects. Hope you'll be enlightened if not content.

View all posts by adminglobal →

Leave a Reply

Your email address will not be published. Required fields are marked *

Social media & sharing icons powered by UltimatelySocial
Facebook
Facebook
Twitter
Visit Us
Pinterest
LinkedIn
Instagram